Caption: Picture 4
Lim K, Ryu S, Ohishi Y, Watanabe I, Tomi H, Suh H et al
In addition, if dosing is in fact quarterly instead of the once-weekly dosing for current obesity treatments, manufacturing could be less demanding.
Meanwhile, in January 1996 the first rodent study suggested that GLP-1 could be a central regulator of feeding behavior and satiety based on intracerebroventricular injection studies [4], but soon thereafter the results of other rodent studies using peripherally injected GLP-1 argued against an appetite effect [5]
The combination addresses more pathways simultaneously: the fat burner handles thermogenesis, appetite, and energy, while L-Carnitine handles the mitochondrial transport of the liberated fatty acids